ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.28
0.13%
US Tech 100
19,488.66
-0.46%
S&P 500
5,742.58
-0.05%
US Dollar vs CAD
1.35039
0.20%
Bitcoin
66,203.19
1.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. XOMA Royalty Corporation (XOMA)

  7. XOMA Royalty Corporation (XOMA) News

XOMA

XOMA Royalty (XOMA)

XOMA Royalty Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XOMA
DateTimeSourceHeadlineSymbolCompany
09/23/20245:30AMGlobeNewswire Inc.Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)NASDAQ:XOMAXOMA Royalty Corporation
09/23/20244:30AMGlobeNewswire Inc.XOMA Royalty Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Royalty Corporation
09/04/20246:30AMGlobeNewswire Inc.XOMA Royalty to Present at Upcoming Investor Conferences in SeptemberNASDAQ:XOMAXOMA Royalty Corporation
08/13/20246:30AMGlobeNewswire Inc.XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAXOMA Royalty Corporation
06/20/20246:30AMGlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Royalty Corporation
06/12/20246:30AMGlobeNewswire Inc.XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review VoucherNASDAQ:XOMAXOMA Royalty Corporation
05/14/20246:30AMGlobeNewswire Inc.XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQNASDAQ:XOMAXOMA Royalty Corporation
05/09/20246:30AMGlobeNewswire Inc.XOMA Reports First Quarter 2024 Financial Results and Highlights Recent ActivitiesNASDAQ:XOMAXOMA Royalty Corporation
04/30/20246:30AMGlobeNewswire Inc.XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%NASDAQ:XOMAXOMA Royalty Corporation
04/25/20246:30AMGlobeNewswire Inc.XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)NASDAQ:XOMAXOMA Royalty Corporation
04/24/20248:00AMPR Newswire (US)Actym Therapeutics Appoints Thomas Smart as CEONASDAQ:XOMAXOMA Royalty Corporation
04/03/20248:00AMGlobeNewswire Inc.XOMA Corporation Announces Closing of Tender OfferNASDAQ:XOMAXOMA Royalty Corporation
03/21/20246:30AMGlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Royalty Corporation
03/19/20243:05PMGlobeNewswire Inc.XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.NASDAQ:XOMAXOMA Royalty Corporation
03/08/20246:30AMGlobeNewswire Inc.XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder ValueNASDAQ:XOMAXOMA Royalty Corporation
02/28/20246:30AMGlobeNewswire Inc.XOMA to Present at Upcoming Investor Conferences in MarchNASDAQ:XOMAXOMA Royalty Corporation
02/16/20247:00AMGlobeNewswire Inc.XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value RightNASDAQ:XOMAXOMA Royalty Corporation
01/18/20247:30AMGlobeNewswire Inc.XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® AcquisitionNASDAQ:XOMAXOMA Royalty Corporation
01/11/20243:50PMDow Jones NewsXoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for ArimoclomolNASDAQ:XOMAXOMA Royalty Corporation
01/11/20243:05PMGlobeNewswire Inc.FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRxNASDAQ:XOMAXOMA Royalty Corporation
01/08/20246:30AMGlobeNewswire Inc.XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of DirectorsNASDAQ:XOMAXOMA Royalty Corporation
01/02/20246:30AMGlobeNewswire Inc.XOMA Announces Stock Repurchase Program of up to $50 MillionNASDAQ:XOMAXOMA Royalty Corporation
12/20/20236:30AMGlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Royalty Corporation
12/19/20236:30AMGlobeNewswire Inc.XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® RoyaltiesNASDAQ:XOMAXOMA Royalty Corporation
11/07/20236:30AMGlobeNewswire Inc.XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder ValueNASDAQ:XOMAXOMA Royalty Corporation
10/31/20236:30AMGlobeNewswire Inc.XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)NASDAQ:XOMAXOMA Royalty Corporation
09/25/20236:30AMGlobeNewswire Inc.XOMA Declares Quarterly Preferred Stock DividendsNASDAQ:XOMAXOMA Royalty Corporation
09/06/20236:30AMGlobeNewswire Inc.XOMA to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:XOMAXOMA Royalty Corporation
08/08/20236:30AMGlobeNewswire Inc.XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization StrategyNASDAQ:XOMAXOMA Royalty Corporation
06/23/20235:14PMGlobeNewswire Inc.XOMA Added to the Russell 2000® and Russell 3000® IndexesNASDAQ:XOMAXOMA Royalty Corporation
 Showing the most relevant articles for your search:NASDAQ:XOMA

Your Recent History

LSE
ZT92
Roy.bk.can.28
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved